Implications for policy and practice
chronic disease
DISEASE, CHRONIC DISEASE
To our knowledge, this is the first study conducted in Portugal and one of the few worldwide on disease management alongside a pharmacy-based controlled trial, incorporating DCE and WTA into an economic evaluation using CBA.This study can be used to guide the design and implementation of pharmacy collaborative interventions with primary care with the potential for reimbursement for uncontrolled or at-risk chronic disease patients informed by patient preferences.